High-throughput screening technologies allow the identification of genes and proteins essential for mammalian cell division. However, the underlying complexity and connectivity of different biological processes, such as signal transduction, transcription, translation and proteolysis make it difficult to understand the mammalian cell cycle based on the analysis of its individual components alone. The recent development of robust and precise assays to study the mammalian cell cycle, in combination with functional genomics and proteomics, together provide the necessary tools to address this critical issue. With the implementation of different "Omics" technologies for quantitative and high-throughput data acquisition, the possibility of obtaining a more detailed view of the mammalian cell cycle is now realistic. Here, we review RNAi reagents, assays and validation strategies for the identification of genes functioning in the human cell cycle, and outline genomic, proteomic and microscopic approaches to further characterize their specific functions. While a fully integrated model of mammalian cell division remains a distant goal, a framework of a systems understanding of this medically relevant process is beginning to emerge.
RNAi Reagents for Cell Cycle Analysis in Human Cells
Just ten years ago Fire and Mello discovered that double-stranded (ds)RNA molecules trigger the destruction of homologous mRNAs in C. elegans, a phenomenon named RNA interference (RNAi). 1 RNAi has since been shown to be a conserved gene silencing mechanism among eukaryotes, including mammals. 2 In mammalian cells RNAi can be mediated through chemically synthesized siRNAs, endoribonuclease-prepared siRNAs (esiRNAs) and vector-expressed short hairpin (sh)RNAs. [3] [4] [5] [6] [7] [8] Chemically synthesized siRNAs are the most commonly used reagents for RNAi experiments and are readily available with genome-coverage from many commercial sources. siRNAs can be directly transferred into the cell's cytoplasm by either lipofection or electroporation, where they trigger transient mRNA knockdown. An alternative to relatively expensive chemical synthesis is the enzymatic digestion of long dsRNA into heterogeneous pools of siRNAs in vitro by RNase III or Dicer, referred to as endoribonuclease-prepared siRNA (esiRNA). 9 shRNAs require the synthesis of DNA oligonucleotides that have been cloned into an expression vector. First, the resulting shRNA plasmid needs to be introduced into the nucleus where it is transformed into short double stranded hairpin RNA before being exported back into the cytoplasm and finally converted into siRNAs by the Dicer enzyme. A variety of shRNA expression vectors, including inducible shRNA expression systems, [3] [4] [5] [6] have been developed, and single shRNA constructs and libraries are readily available from commercial suppliers.
All three RNAi methods have now been used for large-scale cell cycle/cell division screens in human cells. [10] [11] [12] [13] The target sequences of siRNA, esiRNA and shRNA libraries used in these studies were optimized in silico to maximize their silencing efficacy. Although all three methods can efficiently mediate gene silencing, 14 there exist intrinsic differences, which make them advantageous, or disadvantageous, depending on the applications. The major difference between (e)siRNAs and shRNAs is that (e)siRNAs directly trigger gene silencing once introduced into the cytoplasm of the cells, whereas shRNAs have to be expressed from a vector in the cell nucleus to trigger RNAi. The transfection of plasmid DNA, however, is less efficient and typically more toxic than the delivery methods used for siRNAs and (e)siRNAs which only need to be transferred into the cytoplasm. On the other hand, vector-expressed shRNAs enable long-term knockdown and hence, the ability to perform selectionbased screens. This is incompatible with the transient knockdown (3-5 days) usually obtained with siRNAs and esiRNAs. In addition, an advantage of shRNAs is that they can be delivered via lenti-and retroviruses, mediating efficient transfer of the silencing trigger into cells with inefficient transfection rates, including primary cells. A disadvantage of shRNAs, in contrast to (e)siRNAs, is that the concentration of intracellularly expressed RNAi triggers are difficult to control. This is especially critical in the light of off-target effects in RNAi experiments. [15] [16] [17] [18] Because off-target effects can be concentration-dependent, close control of the silencer concentration delivered to the cells is critical to reduce unspecific side effects. Off-target effects in RNAi experiments can be further reduced by using highly complex pools of siRNAs. 14, 19 to study cell cycle progression and cell division in mammalian tissue culture cells. For example, the degree of cell proliferation under various conditions (e.g., RNAi or chemical library) can be monitored by standard spectrophotometric quantification of the conversion of the cell proliferation reagent WST-1 to Formazan. 20 DNA content analysis is also widely used as readout in high-throughput cell cycle studies and can be measured either by conventional flow cytometry, 21 laser-scanning cytometry, 12 or fluorescence microscopy. 10, 11, 22 DNA content analyses allow the determination of the percentage of cells in a population at distinct cell cycle stages (G 1 , S or G 2 /M). The simultaneous determination of the total number of cells (number of DAPI positive cells) and the number of mitotic cells (number of phospho-histone H3 positive cells) is a natural extension of the above strategy and allows the discrimination of cells with 4n DNA content into G 2 and M-phase pools. 10, 11, 14, 22 On the one hand, end-point assays allow the rapid screening of a high number of samples. On the other hand, the readout is often of low resolution. Importantly, end-point assays offer little time-resolution, hence making it difficult to completely comprehend the contribution of any given protein given the dearth of dynamic information. Indeed, cell cycle progression and cell division are marked by a plethora of highly dynamic events that include chromosome condensation, congression and segregation, mitotic spindle assembly, centrosome duplication and maturation and cytokinesis. Although defects in any of these processes are readily detected in fixed cells stained for various cellular markers, the exact nature, onset and cause of the defects is often not revealed. Therefore, the phenotypic consequences upon depletion should be monitored at different time points. In fact, dynamic processes are best studied using real-time microscopy, ideally at high resolution and in three dimensions.
Automated, climatized microscopes can provide time-lapse sequences from transfected cells plated in 96/384 well plates. Such approaches are well suited for imaging live cells transfected with different silencing triggers, even though the poor optical quality of multi-well plates, and the travel time of the stage, is considerable. The use of solid-phase (e)siRNA, plasmid or chemical arrays has become increasingly popular and provides an alternative transfection assay [23] [24] [25] [26] [27] (Fig. 1 ). First, relatively high-density transfection arrays can be generated at a fraction of the cost of standard transfection procedures. Second, transfection arrays have long shelf lives and the only manipulation required is to plate cells onto the array. Third, arrays can be used either for live cell imaging or stained for various cellular markers using standard fluorescence microscopy. Finally, the relative small physical size of the array increases imaging speed and accuracy. A disadvantage of the spot-array technology is that cells with limited mobility have to be used and the number of cells analyzed is typically smaller due to the small size of the spots. Because statistical methods have to be used to nominate significant hits, a low number of events restrict the power of the statistical methods.
Advances in spot-array technology make it possible to perform the complete genome-wide primary screen as a time-lapse sequence. 27 This raises the following important question when designing a screen: should a rapid end-point assay first be used to quickly identify the most promising candidates that can be studied further using time-lapse assays or should the entire primary screen be performed using a time-lapse assay? The final answer to this question depends on the viewpoint of the individual, but we highlight below some of the issues to be considered. End-point assays offer a rapid way of eliminating the genes that do not function in the process of interest. Hence, with this approach one can rapidly zoom into the genes of interest for high content analysis. The time-lapse assay generates high-resolution data for all genes, including the genes with no function in the process of interest. Because large datasets are collected that do not provide information for the process of interest this increases the time necessary to complete the screen. A longer time-period needed to complete the screen also means that it is probably more expensive to perform the complete primary screen as a time-lapse assay. On the other hand, time-lapse assays provide extremely rich datasets, which can be mined for additional information. For example, an end-point DNA content assay provides one measurement of the amount of DNA in the nucleus of each cell. The time-lapse assay can provide this information throughout the assay period, and the image stacks can also be reanalyzed to extract other information, such as dynamic changes in nuclear morphology, or cell motility etc. Hence, the time-lapse assay may cover multiple end-point assays at once. Independent of the assay, RNAi screens produce large amounts of data. However, multiplex time-lapse analyses for extended periods of time generate a tremendous amount of data. For example, imaging 30 z-sections every 10 minutes for 24 hours generates approximately 4.5 GB of data. Cutting edge microscopy systems are capable of generating 80 such movies for a total of over 350 GB of data per microscope per day. This obviously raises data storage and processing issues requiring cutting-edge hardware and infrastructure. Perhaps the biggest drawback of genome-wide time-lapse analyses of RNA-induced defects is that they represent a formidable technical challenge and require a sophisticated image analysis infrastructure. Whereas the analysis of high content movies from the hits of the primary end-point assay can be performed by manual inspection of each time-lapse sequence, this is practically impossible when filming all knock-downs on a genome-wide scale. Hence, automated image analysis algorithms have to be used to identify hits. The automated analysis of complex phenotypes in 3 dimensions will pose a significant challenge as there is currently a lack of robust image analysis algorithms suitable for the analysis of high-throughput three-dimensional images. However, further refinement of such algorithms and their implementation in the analysis of three dimensional datasets will lead to the generation of rich datasets that will further our understanding of a multitude of dynamic cellular processes.
Quality Control and Validation of RNAi Screens
The different RNAi reagents discussed all induce mRNA degradation. This will ultimately lead to the depletion of essential cell cycle proteins. The depletion will yield measurable effects once a certain threshold, which varies from protein to protein, is reached. As such, the stability or turnover rate of individual proteins, and the efficacy of mRNA knockdown will have a considerable impact on the presence and onset of phenotypes. The false-negative rate is an important parameter for assessing the quality of RNAi data sets, which is representative of the saturation level of the screen.
Another crucial aspect of large-scale RNAi studies is the specificity of the observed phenotypes. RNAi screens, in particular those using siRNAs and shRNAs, are affected by relatively high rates of false positives largely caused by off-target effects. [15] [16] [17] [18] In addition, experimental errors can further increase the number of false positives. Therefore, candidate genes identified in a primary screen have to be rigorously validated. To identify false-positives caused by experimental errors the primary hit genes should be re-screened, because phenotypes resulting from experimental errors are not reproducible in an independent experiment using the original silencing trigger. Re-screening with at least one independent silencing trigger can identify false-positives caused by off-target effects. Here, the use of an alternative silencing technology (e.g., esiRNA for hits identified in a primary screen using siRNA or vice versa) will increase the confidence in the specificity of an RNAi phenotype.
Instead of validating hits in a secondary screen, multiple single (e)siRNAs/shRNAs can be individually screened in the primary screen and hits are only scored if the same phenotype is observed with more than one silencing trigger. However, this approach is considerably more expensive due to increased use of reagents.
Although the verification of a phenotype with multiple independent silencing triggers reduces the number of false-positives, this approach does not ultimately link an observed phenotype to the gene silenced by RNAi. The most powerful validation strategy for this purpose is a genetic rescue experiment. For RNAi experiments, a rescue experiment can be done by introducing silent mutations into the transcript sequence that is targeted by the silencing trigger in a cDNA. 28 Expression of the protein from this modified construct should prevent the depletion of the transcript after transfection of the silencing trigger and, hence, the phenotype observed in wildtype cells (e.g., a mitotic arrest) should not occur. As a modification of this protocol, a cDNA construct without modifications can be used when the silencing trigger targets a region in the 3' UTR of the gene, but the utilized cDNA construct carries a different 3' UTR. 28 A problem with this strategy is that expression from cDNA constructs typically do not reflect the expression of the endogenous gene. Hence, the protein of interest is often misexpressed, which by itself can generate phenotypes. An alternative to cDNAs for the expression of genes is the use of bacterial artificial chromosomes (BACs). These large constructs harbor the gene of interest in its genomic context with its intact exon and intron structure and its 5' and 3' regulatory regions. Therefore, the regulation of the gene with expression levels and splice variants typically resembles the expression of the endogenous gene. 29 Importantly, BAC resources are readily available for many different species from different providers and most genes can be found on a single BAC. Modifications and stable integration of BACs in mammalian cells is also straightforward. Recombineering technology 30 can be applied to introduce silent mutations to make the transcript of the gene of interest resistant to the silencing trigger. Alternatively, an unmodified BAC from a different, but closely related species, e.g., mouse for human genes can be utilized to generate cross species BAC transgenic cell lines. In most cases the sequence from a closely related species will be different enough at the DNA level to guarantee resistance to the silencing trigger, while the protein will be similar enough to functionally replace the endogenous protein. This cross species RNAi rescue approach 29 has validated the function of several genes implicated in mammalian cell division 12, 29, 31 and, hence, may present the most practical way to perform a RNAi rescue experiment.
From Phenotype to Mechanism
RNAi screening is undoubtedly an excellent approach to identify key regulators of cell division in different species. 10, 12, 21, [32] [33] [34] [35] [36] Indeed, many previously uncharacterized genes have now been assigned putative functions in cell division. Sometimes, the phenotypic signature after knockdown of an uncharacterized gene allows a prediction on how the protein may act. For instance, the similarity of the phenotypic profile of C17ORF41 with PCNA suggested that C17ORF41 acts as a DNA clamp loader during S-phase. 12 However, often the mechanism of action of the identified proteins remains illusive and detailed molecular and biochemical work is required to finally place each gene in a pathway. Phenotypic profiling also allows the prediction of novel protein complexes in mammalian cells. For instance, the knockdown of MLL5, NCOR2 and TBL1X all caused a cytokinesis defect and displayed highly similar phenotypic signatures, suggesting that these proteins might functionally interact. 12 This hypothesis was supported by work in budding yeast showing that the orthologues physically interact with histone deacetylase HDAC3 to form the set3 complex. 37 The presence of the transcriptional co-repressor NCOR2, and the histone modifying protein HDAC3, suggested that this complex might regulate the transcription of cell cycle genes and, hence, the cell cycle phenotype was caused by the mis-regulation of cell cycle genes. However, no significant cell cycle transcript changes were observed after depletion of set3 components as measured by microarray experiments (unpublished data). Hence, although a new protein complex could be suggested in mammalian cells based on phenotypic clustering the mechanism of action was not revealed.
It is, therefore, important to develop systematic and robust approaches to better characterize the candidates identified in largescale RNAi screens at a molecular level. A reliable and scalable method based on the cross species RNAi rescue approach may be such an approach. A small modification of this approach allows the relatively straightforward tagging of genes and expression of the tagged proteins at near physiological levels from an integrated BAC construct. 29 Recently, a localization and affinity purification (LAP) tag has been developed for mammalian cells that combines the dynamic localization and affinity purification of tagged proteins. 38 Dynamic localization of proteins can provide important clues to decipher the molecular mechanism of proteins. For instance, the knockdown of CASC5 results in an altered ploidy phenotype. 12, 39, 40 The generation of a BAC-tagged cell line expressing a LAP-tagged CASC5 protein showed that the fusion protein localizes to kinetochores before nuclear envelope breakdown and during mitosis ( Fig. 2A-C) , indicating that CASC5 may have a role in kinetochore assembly/function. Consistent with this observation, CASC5 has recently been identified as the mammalian KNL1 orthologue. 12, 39, 40 In the case of the previously mentioned set3 complex the localization of the proteins during mitosis may point to an unanticipated role of this complex during cell division. We observed that the BAC-tagged MLL5 protein is found in foci in the nucleus of cells in interface (Fig. 2D ) consistent with a role of this protein in chromatin regulation during this phase of the cell cycle. However, the MLL5-LAP fusion protein was concentrated on the spindle during mitosis ( Fig. 2E and F) . Importantly, all other set3 components were recently shown to localize to the mitotic spindle as well 41 , suggesting that the human set3 complex plays a role at the mitotic spindle, possibly via its acetylation/deacetylation activity.
The identification of spectral variants of GFP with more efficient folding kinetics and proteins with multiple spectral variants of GFP now available permit the simultaneous imaging of multiple proteins simultaneously. 42 Therefore, it is possible to generate cell lines expressing various organelles labeled with different fluorescent proteins to visualize mitotic processes in real-time. These lines can be transfected with RNAi reagents to monitor the impact of depleting individual proteins on mitotic processes, such as chromosome segregation (H2B-GFP) and spindle assembly (Tubulin-RFP). Such approaches will help to obtain a better understanding of the role of individual proteins in mitotic processes and provide insights on the molecular roles that govern their function.
Another useful method to decipher the mechanism of an RNAi phenotype is proteomics. An impressive example of the usefulness of proteomic data to explain a loss-of-function phenotype is the dissection of the gene shugoshin (SGO1). An important role of SGO1 during mitosis can be inferred from the RNAi phenotype. Depletion of SGO1 causes a mitotic arrest with an initial formation of a metaphase plate followed by the departure of individual chromatids from the metaphase plate, and a persisting cell cycle arrest. 43 A mechanistic explanation of this phenotype was found upon analysis of the protein interaction partners of SGO1. Immunoprecipitations using the BAC-tagging approach demonstrated that SGO1 recruits the phoshatase PP2A to centromers to organize the timely destruction of cohesin. 31, 44 The absence of SGO1 leads to an early degradation of cohesin at centromers, explaining the escape of chromatids from the metaphase plate, which in turn activates the mitotic checkpoint to arrest the cells in mitosis.
Towards an Integrated Model of Mammalian Cell Division
Cell cycle screens establish the fundamental basis for a systems understanding of the mammalian cell cycle, in that they provide a list of players involved in this process. Without a comprehensive view of all the genes implicated in cell cycle progression any model put forward can be incomplete and misleading. Unfortunately, a simple list of the number of genes implicated in cell cycle progression is not sufficient to build meaningful models of the cell cycle. This can only be achieved through the collection and integration of different datasets, which can ultimately lead to a better understanding of the relationship between the different proteins within the cell. The examples discussed in the previous sections provide compelling evidence that combining phenotypic, dynamic subcellular localization and proteomic data is a powerful approach for a better understanding of the molecular mechanisms that govern the cell cycle. It is, therefore, of importance to further develop high throughput technologies for localization and proteomic studies in mammalian cells. Large-scale tagging of proteins at endogenous expression levels has been extremely useful in yeast, especially for the comprehensive protein localization studies 45 and to decipher the yeast protein interaction network. 46 recently developed a scalable BAC-tagging approach which allows the generation of human cell line collections expressing physiological levels of tagged proteins. 48 While technically challenging, it is, in principle, possible to obtain localization and proteomic data for all proteins implicated in cell cycle progression using this TransgeneOmics approach. The combination of phenotypic, localization, and proteomic datasets should be useful to place the identified cell cycles genes into mechanistic pathways ( Fig. 3) and to provide further insights to generate novel and comprehensive models of the mammalian cell cycle.
